27/06/2022

Activity of olaparib in patients with BRCA-mutated early breast cancer

20/06/2022

A breakthrough in the treatment of advanced breast cancer

13/06/2022

First positive results with a CAR-T therapy plus pembrolizumab in malignant pleural mesothelioma

06/06/2022

Breast cancer regression with a trispecific antibody

30/05/2022

Promising results with alpesilib plus olaparib in advanced triple-negative breast cancer

23/05/2022

Promising antitumor activity of rucaparib and sacituzumab govitecan

16/05/2022

Safety and activity of the selective FGFR 1-3 inhibitor pemigatinib

09/05/2022

Breast tumor microenvironment structures are associated with clinical outcomes

02/05/2022

A new screening platform to discover novel KRAS inhibitors